FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977220092> ?p ?o ?g. }

• W1977220092 endingPage "346" @default.
• W1977220092 startingPage "339" @default.
• W1977220092 abstract "Introduction The activation of human vascular smooth muscle cell proliferation, adhesion and migration is essential for intimal hyperplasia formation. These experiments were designed to test whether zoledronic acid (ZA) would modulate indices of human smooth muscle cell activation, exert differential effects on proliferating versus quiescent cells, and determine whether these effects were dependent on GTPase binding proteins prenylation. ZA was chosen for testing in these experiments because it is clinically used in humans with cancer, and has been shown to modulate rat smooth muscle cell proliferation and migration. Methods Human aortic smooth muscle cells (HASMC) were cultured under either proliferating or growth arrest (quiescent) conditions in the presence or absence of ZA for 48 hours, whereupon the effect of ZA on HASMC proliferation, cellular viability, metabolic activity, and membrane integrity were compared. In addition, the effect of ZA on adhesion and migration were assessed in proliferating cells. The effect of increased concentration of ZA on the mevalonate pathway and genomic/cellular stress related poly-adenosine diphosphate ribose polymerase enzyme activity were assessed using the relative prenylation of Rap-1A/B protein and the formation of poly adenosine diphosphate-ribosylated protein, respectively. Results There was a dose dependent inhibition of cellular proliferation, adhesion and migration following ZA treatment. ZA treatment decreased indices of cellular viability and significantly increased membrane injury in proliferating versus quiescent cells. This was correlated with the appearance of unprenylated Rap-1A protein and dose dependent down regulation of activity. Conclusions These data suggest that ZA is effective in inhibiting HASMC proliferation, adhesion, and migration, which coincide with the appearance of unprenylated RAP-1A/B protein, thereby suggesting that the mevalonate pathway may play a role in the inhibition of HASMC activation." @default.
• W1977220092 created "2016-06-24" @default.
• W1977220092 creator A5011153423 @default.
• W1977220092 creator A5012438754 @default.
• W1977220092 creator A5015053978 @default.
• W1977220092 creator A5024817793 @default.
• W1977220092 creator A5034319347 @default.
• W1977220092 creator A5045318472 @default.
• W1977220092 creator A5065972441 @default.
• W1977220092 date "2013-06-01" @default.
• W1977220092 modified "2023-09-26" @default.
• W1977220092 title "Differential effect of zoledronic acid on human vascular smooth muscle cells" @default.
• W1977220092 cites W1585966599 @default.
• W1977220092 cites W1737973269 @default.
• W1977220092 cites W1828920282 @default.
• W1977220092 cites W1970606222 @default.
• W1977220092 cites W1970993628 @default.
• W1977220092 cites W1971943099 @default.
• W1977220092 cites W1976657269 @default.
• W1977220092 cites W1978228601 @default.
• W1977220092 cites W1980832911 @default.
• W1977220092 cites W1984390348 @default.
• W1977220092 cites W1985740124 @default.
• W1977220092 cites W1987745966 @default.
• W1977220092 cites W1990455553 @default.
• W1977220092 cites W1991042231 @default.
• W1977220092 cites W2001935609 @default.
• W1977220092 cites W2005710232 @default.
• W1977220092 cites W2019240387 @default.
• W1977220092 cites W2033451240 @default.
• W1977220092 cites W2041367424 @default.
• W1977220092 cites W2041428916 @default.
• W1977220092 cites W2053161801 @default.
• W1977220092 cites W2054866866 @default.
• W1977220092 cites W2055834907 @default.
• W1977220092 cites W2056647289 @default.
• W1977220092 cites W2057948345 @default.
• W1977220092 cites W2059815044 @default.
• W1977220092 cites W2067592470 @default.
• W1977220092 cites W2068143014 @default.
• W1977220092 cites W2076019958 @default.
• W1977220092 cites W2078043377 @default.
• W1977220092 cites W2086135735 @default.
• W1977220092 cites W2087879911 @default.
• W1977220092 cites W2091959763 @default.
• W1977220092 cites W2099105343 @default.
• W1977220092 cites W2113028183 @default.
• W1977220092 cites W2117425102 @default.
• W1977220092 cites W2118689873 @default.
• W1977220092 cites W2121043418 @default.
• W1977220092 cites W2123706305 @default.
• W1977220092 cites W2129988610 @default.
• W1977220092 cites W2140933156 @default.
• W1977220092 cites W2150950031 @default.
• W1977220092 cites W2163471597 @default.
• W1977220092 cites W2335698550 @default.
• W1977220092 doi "https://doi.org/10.1016/j.jss.2012.10.033" @default.
• W1977220092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3618863" @default.
• W1977220092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23164362" @default.
• W1977220092 hasPublicationYear "2013" @default.
• W1977220092 type Work @default.
• W1977220092 sameAs 1977220092 @default.
• W1977220092 citedByCount "10" @default.
• W1977220092 countsByYear W19772200922013 @default.
• W1977220092 countsByYear W19772200922014 @default.
• W1977220092 countsByYear W19772200922015 @default.
• W1977220092 countsByYear W19772200922016 @default.
• W1977220092 countsByYear W19772200922018 @default.
• W1977220092 countsByYear W19772200922019 @default.
• W1977220092 countsByYear W19772200922020 @default.
• W1977220092 countsByYear W19772200922021 @default.
• W1977220092 crossrefType "journal-article" @default.
• W1977220092 hasAuthorship W1977220092A5011153423 @default.
• W1977220092 hasAuthorship W1977220092A5012438754 @default.
• W1977220092 hasAuthorship W1977220092A5015053978 @default.
• W1977220092 hasAuthorship W1977220092A5024817793 @default.
• W1977220092 hasAuthorship W1977220092A5034319347 @default.
• W1977220092 hasAuthorship W1977220092A5045318472 @default.
• W1977220092 hasAuthorship W1977220092A5065972441 @default.
• W1977220092 hasBestOaLocation W19772200922 @default.
• W1977220092 hasConcept C134018914 @default.
• W1977220092 hasConcept C134651460 @default.
• W1977220092 hasConcept C1491633281 @default.
• W1977220092 hasConcept C151166631 @default.
• W1977220092 hasConcept C181199279 @default.
• W1977220092 hasConcept C185592680 @default.
• W1977220092 hasConcept C2779395532 @default.
• W1977220092 hasConcept C2779982574 @default.
• W1977220092 hasConcept C2992686903 @default.
• W1977220092 hasConcept C53227056 @default.
• W1977220092 hasConcept C55493867 @default.
• W1977220092 hasConcept C57790582 @default.
• W1977220092 hasConcept C62112901 @default.
• W1977220092 hasConcept C62478195 @default.
• W1977220092 hasConcept C85789140 @default.
• W1977220092 hasConcept C86803240 @default.
• W1977220092 hasConcept C95444343 @default.
• W1977220092 hasConceptScore W1977220092C134018914 @default.

• next